NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

Cardinal Health launches interactive map to help pharmacists understand biosimilar laws

by Ed Johnson
August 11, 2021
A A

08/10/2021

New tool is designed to help pharmacies navigate state-by-state interchangeability laws for the FDA’s new regulatory designation

Cardinal Health has created an interactive tool that provides pharmacists with key guidance to help them navigate the recent Food and Drug Administration (FDA) approval of the first interchangeable biologic licensed in the U.S. The FDA approval was given to the long-acting insulin called Semglee (insulin glargine-yfgn), which is now designated as a biosimilar for one of the most widely used and costly biologic treatments on the market today – insulin. 

“The approval of the first interchangeable insulin biosimilar is a big step toward helping bring more affordable diabetes care to the millions of Americans who rely on insulin.”

~Sonia T. Oskouei, vice president of biosimilars at Cardinal Health.

Biosimilars are biologic products that are highly similar to and have no clinically meaningful differences from existing FDA-approved branded biologics.

The FDA’s interchangeability designation will give pharmacists (subject to state law) the ability to substitute a biosimilar for its brand-name product without the intervention of the prescribing physician, similar to a generic. This may put pharmacists in a position to help diabetes patients access their insulin at a lower cost.

Semglee will be the first biosimilar available to a broad patient population through retail pharmacies. Cardinal Health created its interactive map to help pharmacists get up to speed quickly on biosimilars and interchangeability, so they’re able to appropriately educate their patients about their treatment options. Pharmacy laws and practices vary from state to state, particularly when it comes to managing interchangeable biosimilars. State laws include specific requirements related to provider notification and permission, patient communication and documentation practices. Our map details how states define interchangeability, clarifies whether pharmacists can substitute biosimilars, and defines what healthcare providers and pharmacists need to know about switching to a biosimilar.

“The approval of the first interchangeable insulin biosimilar is a big step toward helping bring more affordable diabetes care to the millions of Americans who rely on insulin, but many patients will have questions,” said Sonia T. Oskouei, vice president of biosimilars at Cardinal Health. “As some of the most trusted and accessible healthcare providers in their communities, pharmacists will play an essential role in educating patients about biosimilars, building clinical confidence in these products, and guiding patients toward therapies that deliver the best outcome at the lowest cost. Our map is designed to give pharmacists the answers they need on state-level interchangeability requirements.”

Tags: < Market
ShareTweetShareSend

Related Industries

Healthcare

Medtronic recommends rejection of below-market mini-tender offer by TRC Capital Investment Corporation

January 26, 2023
Healthcare

Johnson & Johnson Reports Q4 and Full-Year 2022 Results

January 25, 2023
Healthcare

Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries

January 18, 2023
Healthcare

AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets

January 11, 2023
Healthcare

Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders

January 7, 2023
Healthcare

Michelle Quinn Named Acting General Counsel for BD

January 7, 2023

UC Investments Creates Strategic Venture with Blackstone to Invest $4 Billion in BREIT Common Shares

January 4, 2023

...

IHG Hotels & Resorts Donates $500,000 to AHLA Foundation Human Trafficking Survivor Fund

January 25, 2023

...

Hyundai Motor America Reports Record-Setting December, Q4 and 2022 Sales

January 5, 2023

...

Emerson Announces Premium, All-Cash Proposal to Acquire National Instruments for $53 Per Share

January 18, 2023

...

The Ritz-Carlton Leadership Center Appoints Amanda Joiner as New Global Vice President

January 11, 2023

...

BASF breaks ground on MDI capacity expansion project at Geismar site

January 12, 2023

...

Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, New York

January 4, 2023

...

ABB sells Power Conversion division to AcBel Polytech Inc. for $505 million

January 21, 2023

...

Cargill Wins 2023 BIG Innovation Award

January 12, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

INDUSTRIES

  • Aero
  • Agriculture
  • ALL
  • Automotive
  • Business Service
  • Chemical
  • Construction
  • Construction Materials
  • Consumer
  • Education
  • Energy
  • Entertainment
  • Environmental
  • F&B
  • Financial
  • Healthcare
  • Hospitality
  • Industrial
  • IT
  • IT Hardware
  • Logistic
  • Metal & Mining
  • Packaging & Paper
  • Rail
  • Real Estate
  • Telecom

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.